Brief: Replicel Life Sciences amends terms of private placement
07/10/2016 17:38
Oct 7 (Reuters) - Replicel Life Sciences Inc RP.V :
* Replicel Life Sciences amends terms of private placement
* Agreed to amend terms by reducing exercise price of
warrants and price at which company can force exercise of
warrants
* Offering will consist of to 8 million units at a price of
$0.52 per unit
Source text for Eikon: ID:nCCN6MLdRv
Further company coverage: RP.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector